Back
Macrogenics Vs. NeuroBo Pharmaceuticals Industry Stock Comparison
Sell
46
MGNX
Macrogenics
Last Price:
14.75
Seasonality Move:
34.35%
Sell
39
NRBO
NeuroBo Pharmaceuticals
Last Price:
4.08
Seasonality Move:
-12.96%
Sell
46
Macrogenics (MGNX)
is a Sell
Is Macrogenics a Buy, Sell or Hold?
- The current Macrogenics [MGNX] share price is $14.72. The Score for MGNX is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
- MGNX is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
39
NeuroBo Pharmaceuticals (NRBO)
is a Sell
Is NeuroBo Pharmaceuticals a Buy, Sell or Hold?
- The current NeuroBo Pharmaceuticals [NRBO] share price is $4.15. The Score for NRBO is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
- NRBO is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
MGNX Stock Price Chart
What is Macrogenics's stock price today?
-
The Macrogenics share price today is $14.72
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MGNX is experiencing slight selling pressure.
NRBO Stock Price Chart
What is NeuroBo Pharmaceuticals's stock price today?
-
The NeuroBo Pharmaceuticals share price today is $4.15
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NRBO is experiencing slight selling pressure.
MGNX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.61 | Sell |
Relative Strength Index (14 RSI): | 40.24 | Sell |
Chaikin Money Flow: | -51831 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (14.92 - 19.08) | Sell |
Bollinger Bands (100): | (8.14 - 16.64) | Buy |
NRBO Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.2 | Sell |
Relative Strength Index (14 RSI): | 40.53 | Sell |
Chaikin Money Flow: | -16224 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.32 - 5.68) | Sell |
Bollinger Bands (100): | (3.31 - 4.97) | Buy |
MGNX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 14.9 | Sell |
20-day SMA: | 16.89 | Sell |
50-day SMA: | 16.16 | Sell |
200-day SMA: | 8.72 | Buy |
8-day EMA: | 15.04 | Sell |
20-day EMA: | 15.94 | Sell |
50-day EMA: | 15.35 | Sell |
200-day EMA: | 10.53 | Buy |
NRBO Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.33 | Sell |
20-day SMA: | 4.91 | Sell |
50-day SMA: | 4.65 | Sell |
200-day SMA: | 4 | Buy |
8-day EMA: | 4.37 | Sell |
20-day EMA: | 4.64 | Sell |
50-day EMA: | 4.61 | Sell |
200-day EMA: | 10.27 | Sell |
Macrogenics Earnings Growth & MGNX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.34 per share, a decrease next quarter of $0.00 per share, a decrease this year of $2.90 per share, and an increase next year of $1.65 per share.
NeuroBo Pharmaceuticals Earnings Growth & NRBO Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Macrogenics Technical Analysis
Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
NeuroBo Pharmaceuticals Technical Analysis
Mar 15 | Mar 18 | Mar 19 | Mar 20 | Mar 21 | Mar 22 | Mar 25 | Mar 26 | Mar 27 | Mar 28 | |
---|---|---|---|---|---|---|---|---|---|---|
Mar | ||||||||||
15 | 18 | 19 | 20 | 21 | 22 | 25 | 26 | 27 | 28 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |